KIN - Kindred Biosciences, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5306.87M
Enterprise Value 3230.38M
Trailing P/E N/A
Forward P/E 1-5.95
PEG Ratio (5 yr expected) 1-0.13
Price/Sales (ttm)73.40
Price/Book (mrq)3.22
Enterprise Value/Revenue 355.10
Enterprise Value/EBITDA 6-3.75

Trading Information

Stock Price History

Beta (3Y Monthly) 0.39
52-Week Change 3-37.18%
S&P500 52-Week Change 319.27%
52 Week High 312.99
52 Week Low 35.96
50-Day Moving Average 38.03
200-Day Moving Average 37.60

Share Statistics

Avg Vol (3 month) 3109.97k
Avg Vol (10 day) 3107.12k
Shares Outstanding 539.09M
Float 30.06M
% Held by Insiders 15.87%
% Held by Institutions 157.25%
Shares Short (Nov. 15, 2019) 4693.05k
Short Ratio (Nov. 15, 2019) 47.13
Short % of Float (Nov. 15, 2019) 42.32%
Short % of Shares Outstanding (Nov. 15, 2019) 41.77%
Shares Short (prior month Oct. 15, 2019) 4889.12k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 31, 2018
Most Recent Quarter (mrq)Sep. 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,505.19%

Management Effectiveness

Return on Assets (ttm)-32.95%
Return on Equity (ttm)-61.20%

Income Statement

Revenue (ttm)4.18M
Revenue Per Share (ttm)0.11
Quarterly Revenue Growth (yoy)72.50%
Gross Profit (ttm)1.64M
EBITDA -61.45M
Net Income Avi to Common (ttm)-61.1M
Diluted EPS (ttm)-1.64
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)87.44M
Total Cash Per Share (mrq)2.24
Total Debt (mrq)20.72M
Total Debt/Equity (mrq)21.76
Current Ratio (mrq)9.30
Book Value Per Share (mrq)2.44

Cash Flow Statement

Operating Cash Flow (ttm)-55.52M
Levered Free Cash Flow (ttm)-44.46M